|
Merck has said it doesn't believe Zilmax is the cause of the problems. "We believe in the science that supports Zilmax," the Whitehouse Station, N.J., company said in a press release Friday. Analysts expect Merck to report $44.6 billion in revenue this year, according to FactSet. That includes about $3.5 billion for the company's animal health business, which makes Zilmax. Shares of Merck lost 41 cents to $47.56 in afternoon trading.
Copyright 2013 The Associated Press. All rights reserved. This
material may not be published, broadcast, rewritten or
redistributed.